One-year clinical trial data for the next-generation, investigational, Sphere-360TM single-shot PFA catheter show impressive safety, perf ...

Largest multi-center prospective Investigational Device Exemption (IDE) study for multi-port robotic-assisted urologic ...

Shares of Medtronic PLC MDT rose 1.54% to $84.85 Friday, on what proved to be an all-around favorable trading session for the ...

Omniasecure, which was authorized for placement in the heart’s right ventricle, is the world’s smallest defibrillation lead, ...

Medtronic (NYSE: MDT) today announced a new interim analysis evaluating automated sacral neuromodulation (SNM) therapy.

William Blair analyst Brandon Vazquez said 2025 could be the first year market leader Intuitive Surgical will face meaningful ...

Medtronic (NYSE: MDT) announced that it entered into an agreement to distribute the Retia Medical Argos cardiac output ...

Upon approval, Sphere-360 will be a valuable addition to Medtronic's Affera system, which has been a game changer for Afib treatment and physician workflow." ...

Medtronic confirmed that its Hugo surgical robot system has been submitted to the FDA for review, alongside the successful completion of a large clinical trial evaluating its performance | According ...

GALWAY, Ireland and LAS VEGAS, April 26, 2025 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced that the Expand URO Investigational Device Exemption ...

A judge has issued a permanent injunction, signaling an Insulet (Nasdaq:PODD) victory in a trade secret case against EOFlow.